A citation-based method for searching scientific literature

N George Mikhaeel, Daniel Smith, Joel T Dunn, Michael Phillips, Henrik Møller, Paul A Fields, David Wrench, Sally F Barrington. Eur J Nucl Med Mol Imaging 2016
Times Cited: 143







List of co-cited articles
552 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Bruce D Cheson, Richard I Fisher, Sally F Barrington, Franco Cavalli, Lawrence H Schwartz, Emanuele Zucca, T Andrew Lister. J Clin Oncol 2014
51

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, Michel Meignan, Martin Hutchings, Stefan P Müeller, Lawrence H Schwartz, Emanuele Zucca, Richard I Fisher, Judith Trotman,[...]. J Clin Oncol 2014
829
49

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.
Myriam Sasanelli, Michel Meignan, Corinne Haioun, Alina Berriolo-Riedinger, René-Olivier Casasnovas, Alberto Biggi, Andrea Gallamini, Barry A Siegel, Amanda F Cashen, Pierre Véra,[...]. Eur J Nucl Med Mol Imaging 2014
124
43

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.
Anne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, Michel Meignan, Pierre Vera, Hervé Tilly, Fabrice Jardin, Stéphanie Becker. Clin Cancer Res 2016
101
43

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.
Michel Meignan, Anne Ségolène Cottereau, Annibale Versari, Loïc Chartier, Jehan Dupuis, Sami Boussetta, Ilaria Grassi, René-Olivier Casasnovas, Corinne Haioun, Hervé Tilly,[...]. J Clin Oncol 2016
156
36

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Ronald Boellaard, Roberto Delgado-Bolton, Wim J G Oyen, Francesco Giammarile, Klaus Tatsch, Wolfgang Eschner, Fred J Verzijlbergen, Sally F Barrington, Lucy C Pike, Wolfgang A Weber,[...]. Eur J Nucl Med Mol Imaging 2015
35

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.
Hajira Ilyas, N George Mikhaeel, Joel T Dunn, Fareen Rahman, Henrik Møller, Daniel Smith, Sally F Barrington. Eur J Nucl Med Mol Imaging 2018
64
48


Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
Mathieu Nessim Toledano, P Desbordes, A Banjar, I Gardin, P Vera, P Ruminy, F Jardin, H Tilly, S Becker. Eur J Nucl Med Mol Imaging 2018
45
64

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement.
Moo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, Sang-Min Lee, Su-Ee Lee, Ho-Sup Lee, Gyeong-Won Lee, Seong-Jang Kim, Seok-Mo Lee, Dong-Seop Chung. Ann Hematol 2012
95
29

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.
Zheng Zhou, Laurie H Sehn, Alfred W Rademaker, Leo I Gordon, Ann S Lacasce, Allison Crosby-Thompson, Ann Vanderplas, Andrew D Zelenetz, Gregory A Abel, Maria A Rodriguez,[...]. Blood 2014
489
26

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J Savage, Tamara Shenkier, Judy Sutherland,[...]. Blood 2007
900
24

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
Ulrich Dührsen, Stefan Müller, Bernd Hertenstein, Henrike Thomssen, Jörg Kotzerke, Rolf Mesters, Wolfgang E Berdel, Christiane Franzius, Frank Kroschinsky, Matthias Weckesser,[...]. J Clin Oncol 2018
94
25

Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.
Michel Meignan, Myriam Sasanelli, René Olivier Casasnovas, Stefano Luminari, Federica Fioroni, Chiara Coriani, Helene Masset, Emmanuel Itti, Paolo G Gobbi, Francesco Merli,[...]. Eur J Nucl Med Mol Imaging 2014
103
24


Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Anne-Ségolène Cottereau, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Romain Ricci, Stéphane Bardet, Antonio Castagnoli, Pauline Brice, John Raemaekers,[...]. Blood 2018
75
29

Revised response criteria for malignant lymphoma.
Bruce D Cheson, Beate Pfistner, Malik E Juweid, Randy D Gascoyne, Lena Specht, Sandra J Horning, Bertrand Coiffier, Richard I Fisher, Anton Hagenbeek, Emanuele Zucca,[...]. J Clin Oncol 2007
22

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J M Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini,[...]. Blood 2015
94
21

Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial.
Christine Schmitz, Andreas Hüttmann, Stefan P Müller, Maher Hanoun, Ronald Boellaard, Marcus Brinkmann, Karl-Heinz Jöckel, Ulrich Dührsen, Jan Rekowski. Eur J Cancer 2020
35
57

High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loic Chartier, Christophe Fruchart, Louise Roulin, Lucie Oberic, Gian Matteo Pica,[...]. Blood 2020
39
51

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, Christoph Renner, Thomas Pabst, Christoph Driessen, Ulrich Mey, Miklos Pless, Mario Bargetzi, Fatime Krasniqi,[...]. J Clin Oncol 2015
117
19

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Hugo J A Adams, John M H de Klerk, Rob Fijnheer, Ben G F Heggelman, Stefan V Dubois, Rutger A J Nievelstein, Thomas C Kwee. Eur J Haematol 2015
43
41

Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.
Qaid Ahmed Shagera, Gi Jeong Cheon, Youngil Koh, Min Young Yoo, Keon Wook Kang, Dong Soo Lee, E Edmund Kim, Sung-Soo Yoon, June-Key Chung. Eur J Nucl Med Mol Imaging 2019
29
62

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.
Alison J Moskowitz, Heiko Schöder, Somali Gavane, Katie L Thoren, Martin Fleisher, Joachim Yahalom, Susan J McCall, Briana R Cadzin, Stephanie Y Fox, John Gerecitano,[...]. Blood 2017
69
24


An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.
Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger, Alberto Biggi, Amanda F Cashen, Pierre Véra, Hervé Tilly, Barry A Siegel, Andrea Gallamini, René-Olivier Casasnovas,[...]. Eur J Nucl Med Mol Imaging 2013
162
16

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.
Tae Min Kim, Jin Chul Paeng, In Kook Chun, Bhumsuk Keam, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Dong Soo Lee, Chul Woo Kim, June-Key Chung,[...]. Cancer 2013
104
16

18F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome.
Anne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Jérôme Clerc, Franck Morschhauser, Olivier Casasnovas, Michel Meignan, Irène Buvat. J Nucl Med 2020
39
41

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).
A S Cottereau, S Becker, F Broussais, O Casasnovas, S Kanoun, M Roques, N Charrier, S Bertrand, R Delarue, C Bonnet,[...]. Ann Oncol 2016
57
26

F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.
Rosj Gallicchio, Giovanna Mansueto, Vittorio Simeon, Anna Nardelli, Roberto Guariglia, Daniela Capacchione, Ernesto Soscia, Piernicola Pedicini, Domenico Gattozzi, Pellegrino Musto,[...]. Eur J Haematol 2014
54
27

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma.
Salim Kanoun, Ilan Tal, Alina Berriolo-Riedinger, Cédric Rossi, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Louis Legrand, Olivier Humbert, Olivier Casasnovas, François Brunotte,[...]. PLoS One 2015
64
23

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Bertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, Gérard Lepeu, Isabelle Plantier, Sylvie Castaigne, Sophie Lefort, Gérald Marit, Margaret Macro, Catherine Sebban,[...]. Blood 2010
895
14

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study.
R-O Casasnovas, L Ysebaert, C Thieblemont, E Bachy, P Feugier, A Delmer, S Tricot, J Gabarre, M Andre, C Fruchart,[...]. Blood 2017
54
25

Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma.
Salim Kanoun, Cédric Rossi, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Alexandre Cochet, Olivier Humbert, Michel Toubeau, Emmanuelle Ferrant, François Brunotte, René-Olivier Casasnovas. Eur J Nucl Med Mol Imaging 2014
96
14

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
H Tilly, M Gomes da Silva, U Vitolo, A Jack, M Meignan, A Lopez-Guillermo, J Walewski, M André, P W Johnson, M Pfreundschuh,[...]. Ann Oncol 2015
402
14

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.
René-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, Anne Julian, Catherine Thieblemont, Pierre Vera, Serge Bologna, Josette Brière, Jean-Philippe Jais,[...]. Blood 2011
209
13


CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Bertrand Coiffier, Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard,[...]. N Engl J Med 2002
13

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Barbara Botto, Simone Ferrero, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Giorgio Limerutti, Massimo Menga,[...]. Blood 2012
167
12

Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation.
Mani Akhtari, Sarah A Milgrom, Chelsea C Pinnix, Jay P Reddy, Wenli Dong, Grace L Smith, Osama Mawlawi, Zeinab Abou Yehia, Jillian Gunther, Eleanor M Osborne,[...]. Blood 2018
44
27

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.
Michel Meignan, Andrea Gallamini, Michel Meignan, Andrea Gallamini, Corinne Haioun. Leuk Lymphoma 2009
455
12

Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients.
Anne-Ségolène Cottereau, Tarec Christoffer El-Galaly, Stéphanie Becker, Florence Broussais, Lars Jelstrup Petersen, Christophe Bonnet, John O Prior, Hervé Tilly, Martin Hutchings, Olivier Casasnovas,[...]. J Nucl Med 2018
34
35


From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Richard L Wahl, Heather Jacene, Yvette Kasamon, Martin A Lodge. J Nucl Med 2009
11

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
Christian Gisselbrecht, Bertram Glass, Nicolas Mounier, Devinder Singh Gill, David C Linch, Marek Trneny, Andre Bosly, Nicolas Ketterer, Ofer Shpilberg, Hans Hagberg,[...]. J Clin Oncol 2010
969
11

Metabolic Tumor Volume Metrics in Lymphoma.
Lale Kostakoglu, Stéphane Chauvie. Semin Nucl Med 2018
48
22


The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.
Silvia Park, Seung Hwan Moon, Lee Chun Park, Deok Won Hwang, Jun Ho Ji, Chi Hoon Maeng, Su-Hee Cho, Hee Kyung Ahn, Ji Yean Lee, Seok Jin Kim,[...]. Am J Hematol 2012
33
33

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
11

Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease.
Jihyun Kim, Junshik Hong, Seog Gyun Kim, Kyung Hoon Hwang, Minsu Kim, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Dong Bok Shin,[...]. Nucl Med Mol Imaging 2014
30
36


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.